Evidence map›Paper›PMID 40283974›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) Regimen.

Esraa K Abdelfattah, Sanaa M Hosny, Amira B Kassem, Hebatallah Ahmed Mohamed Moustafa, Amany M Tawfeik, Marwa N Abdelhafez, Wael El-Sheshtawy, Bshra A Alsfouk, Asmaa Saleh, Hoda A Salem

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Esraa K AbdelfattahDepartment of Clinical Pharmacy, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11651, Egypt.ORCID 0009-0008-2248-4399
Sanaa M HosnyDepartment of Clinical Pharmacy, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11651, Egypt.
Amira B KassemClinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Damanhour University, Damanhour 22514, Egypt.ORCID 0000-0003-4195-6036
Hebatallah Ahmed Mohamed MoustafaClinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Badr University in Cairo, Cairo 11829, Egypt.ORCID 0000-0003-4530-406X
Amany M TawfeikMedical Microbiology and Immunology Department, Faculty of Medicine, Badr University in Cairo, Cairo 11829, Egypt.
Marwa N AbdelhafezDepartment of Medical Oncology, National Cancer Institute, Cairo University, Al Giza 12613, Egypt.
Wael El-SheshtawyDepartment of Medical Oncology, Faculty of Medicine, Al Azhar University, Cairo 11651, Egypt.
Bshra A AlsfoukDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0001-6489-6035
Asmaa SalehDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-6286-319X
Hoda A SalemDepartment of Pharmacy Practice, University of Tabuk, Tabuk 47512, Saudi Arabia.ORCID 0000-0001-6089-6062

Funding

Princess Nourah bint Abdulrahman University PNURSP2025R142
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AC regimenrs1045642rs12248560rs2228100rs6907567single-nucleotide polymorphismSNP

Identifiers

PMID40283974
PMCPMC12029990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.